PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Andy Bryant
Thomas Chadwick
Mike Cole
Trinh Dong
Chioma Elewa
Holly Fisher
Tony Fouweather
Sophie Greenwood
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Ellen Moss
Helen Mossop
Aritra Mukherjee
Ayon Mukherjee
Jérémie Nsengimana
Marzieh Shahmandi
Konstantin Shestopaloff
Moha Shojaei
David Sinclair
Elaine Stamp
James Wason
Nina Wilson
Yingjuan Zhang
PhD students
Nicole Cizauskas
Emily Clements
Niamh Fitzgerald
Raiann Hamshaw
Prika Huang
Ben Keane
Sofiia Kravchenko
Laura Morgan
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
Prognostic significance of promoter hypermethylation and diminished gene expression of SYNPO2 in melanoma
Gao L
,
van den Hurk K
,
Nsengimana J
,
Laye JP
,
van den Oord JJ
,
Beck S
,
Gruis NA
,
Zoutman WH
,
van Engeland M
,
Newton-Bishop JA
,
Winnepenninckx VJ
,
van Doorn R
September 2015
DOI
Type
Journal article
Publication
Journal of Investigative Dermatology
2015; 135(9):2328-2331
Nsengimana
Related
Peroxiredoxin-2 represses NRAS-mutated melanoma cells invasion by modulating EMT markers
Immune subtyping of melanoma whole slide images using multiple instance learning
Utilising high-dimensional data in randomised clinical trials: A review of methods and practice
ROR2 promotes epithelial-mesenchymal transition by hyperactivating ERK in melanoma
Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk
Cite
×